Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "ticker"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.2/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the readOnly/idempotent annotations, the description discloses fan-out behavior across multiple sources, the meaning of `sources_used`/`sources_failed`, and that 'an empty section is a real no-data, not a bug.' It also explains name resolution via SEC EDGAR and the private-company resolved:false behavior, adding substantial non-obvious context.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The opening is front-loaded with examples and the core purpose, but the middle becomes a dense run-on parenthetical listing sources and returns, including artifacts like 'sorted?'. It also repeats schema content at the end regarding type interchangeability, adding some noise.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

There is no output schema, so the description carries the burden of describing return values. It enumerates the major returned sections (cik, recent_filings, fundamentals, patents, contracts, biologics, hiring, news, LEI, sources_used/failed) and covers edge cases. It does not detail the internal structure of every section, but for a profile tool this is sufficient.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, and both `type` and `value` are already clearly documented in the input schema. The description adds concrete examples ('AAPL', '0000320193', 'Moderna') and restates that `type` values are interchangeable, but no significant new parameter meaning beyond the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a specific verb and resource: 'full cross-source profile of a US public company in ONE parallel call.' It includes concrete trigger examples ('Tell me about X', 'research Acme') and explicitly distinguishes itself from chaining single-pack SEC/XBRL/news lookups, making its purpose unmistakable.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives an explicit when-to-use directive: 'ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view.' It lacks an explicit when-not list for private or non-US companies, but does note that private companies return resolved:false, which implies a boundary.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation2/5

Several tool clusters have genuinely blurry boundaries: ask_pipeworx, ask_pipeworx_beta (explicitly 'currently matches ask_pipeworx exactly'), ask_pipeworx_grounded, and deep_research all route questions to the same 5,743-tool catalog, and the six Polymarket tools (bet_research, polymarket_edges, polymarket_arbitrage, polymarket_edge_tracker, polymarket_fill_risk, polymarket_kalshi_spread) heavily overlap on 'should I bet / where is the edge'. The descriptions are detailed and cross-reference each other, but an agent would still struggle to pick correctly among near-duplicates.

Naming Consistency3/5

Everything is uniformly snake_case and readable, but there is no consistent verb_noun pattern: verb_noun (resolve_entity, discover_tools, validate_claim) mixes with noun_noun (domain_search, entity_profile, polymarket_arbitrage), adjective_noun (deep_research, recent_changes), bare verbs (forget, recall, remember), and brand prefixes (pipeworx_*, ask_pipeworx_*). Readable, but patternless.

Tool Count2/5

34 tools is well above the heavy threshold, but the bigger issue is scope incoherence: a server named 'Hunter' dedicates only 3 of 34 tools to Hunter.io email lookup while the remaining 31 belong to an unrelated Pipeworx data-research/prediction-market platform. The count is not earned by a single coherent purpose.

Completeness3/5

The Pipeworx research core is quite thorough: entity resolution, single-lookup, grounded answers, deep research, profiles, comparisons, claim validation, semantic search-within-records, change feeds, subscriptions, and memory form a full research lifecycle. However, the domain is a grab-bag spanning email finding, npm dependency checking, prediction markets, and data research, and the three Hunter.io tools that match the server name are only a thin fragment of the surface.